|
Match
|
Document |
Document Title |
|
|
7604820 |
Solid preparation containing chitosan powder and process for producing the same
A colonic delivery solid preparation containing chitosan powder, which can control the dissolution of a medicament therefrom in the large intestine and release the medicament contained therein...
|
|
|
7541347 |
Minocycline oral dosage forms for the treatment of acne
Minocycline oral dosage forms containing a controlled release carrier are useful for the treatment of acne.
|
|
|
7465462 |
Multiparticulate controlled release selective serotonin reuptake inhibitor formulations
A multiparticulate controlled release selective serotonin reuptate inhibitor (SSRI) formulation for oral administration is provided. The formulation includes particles of an SSRI or a...
|
|
|
7381227 |
Fabric laundering
Relatively low levels of polysaccharides in combination with small, deformable, water-insoluble particles of a size in the range 0.05-5 microns are capable of giving benefits in a wash liquor in...
|
|
|
7364754 |
Ceramic based nanoparticles for entrapping therapeutic agents for photodynamic therapy and method of using same
The present invention provides methods and compositions for photodynamic therapy. The composition comprises ceramic nanoparticles in which a photosensitive drug/dye is entrapped. The ceramic...
|
|
|
7316821 |
Stabilized controlled release substrate having a coating derived from an aqueous dispersion of hydrophobic polymer
A stabilized solid controlled release dosage form having a coating derived from an aqueous dispersion of ethylcellulose is obtained by overcoating a substrate including a therapeutically active...
|
|
|
7309500 |
Microparticles
A method of forming particles, comprises accelerating a first stream comprising a first liquid, applying a charging voltage of at most 1.5 kV to the first stream, and vibrating the first stream, to...
|
|
|
7235261 |
Controlled release encapsulation
This invention relates to a controlled release encapsulated dry powder that is formed by an emulsion comprising: A) a fully hydrolyzed polymer, B) a hydrophobic silica, C) a modified corn starch,...
|
|
|
7223421 |
Teste masked pharmaceutical particles
Taste masked particles and chewable tablets made therefrom are disclosed. The taste masked particles comprise a core containing an active ingredient and a polymeric coating covering said core, said...
|
|
|
7220433 |
Compositions for parenteral administration and sustained-release of therapeutic agents
The present invention is directed to parenterally-administrable microparticles for providing sustained-release of a therapeutic agent in the body, where the microparticles include a polymeric core...
|
|
|
7078058 |
Corticosteroid-containing pharmaceutical composition
A foamable pharmaceutical composition comprising a corticosteroid, a quick-break foaming agent, a propellant and a buffering agent, sufficient to buffer the composition to within the range of pH...
|
|
|
7074430 |
Controlled release tramadol tramadol formulation
A controlled release preparation for oral administration contains tramadol, or a pharmaceutically acceptable salt thereof, as active ingredient.
|
|
|
7018657 |
Particulate composition
Nanoparticles are prepared from a colloidal system comprising a continuous phase and micelles, the micelles comprising surfactant material. A microemulsion is formed by admixing the colloidal...
|
|
|
6994873 |
Multiparticulate formulations of lithium salts for oral administration suitable for once-a-day administration
This invention refers to:
multiparticulate formulations of Lithium salts for oral administration constituted by either modified release granules or mixtures of modified and conventional...
|
|
|
6989159 |
Pharmaceutical compositions containing lithium carbonate
Once daily pharmaceutical compositions containing lithium carbonate in the form of coated granules.
|
|
|
6951657 |
Particles coated with granulated crystalline ibuprofen
The invention concerns coated particles based on granulated microcrystals of ibuprofen, its pharmaceutically acceptable isomers and salts, characterized in that they comprise a coating obtained in...
|
|
|
6946146 |
Coating for a sustained release pharmaceutical composition
The present invention is directed to a coating composition for coating a solid dosage form of a medicament, where the coating composition controls the release of the medicament, said coating...
|
|
|
6939560 |
Pharmaceutical composition having two coating layers
The present invention provides a pharmaceutical composition which is substantially free of unpleasant tastes and orally administrable which comprises:
(a) an active medicament, (b) an inner...
|
|
|
6932984 |
Method of microencapsulation
A method for microencapsulation of substances is provided. The substance(s) is/are dissolved or dispersed in an organic solvent of the kind that is partially miscible in water media. This organic...
|
|
|
6913768 |
Sustained release delivery of amphetamine salts
A pharmaceutical composition comprises a once-a-day sustained release formulation of at least one amphetamine salt which provides mean plasma concentration profile aspects in human ADHD patients...
|
|
|
6911217 |
Controlled release bead, a method of producing the same and multiple unit formulation comprising it
A controlled release bead comprises: (i) a core unit of a substantially water-soluble or water-swellable inert material; (ii) a first layer on the core unit of a substantially water-insoluble...
|
|
|
6890561 |
Microencapsulated and controlled-release formulations of isoflavone from enriched fractions of soy and other plants
There is provided an orally-administrable formulation for the controlled release or stable storage of a granulated isoflavone-enriched fraction or mixture of such fractions, comprising at least one...
|
|
|
6875443 |
Encapsulated long chain alcohols
The present invention is directed to the encapsulation of long chain alcohols, C 20 -C 36 , in various materials including polymers and waxes. Through the proper selection of the polymer the...
|
|
|
6855333 |
Stabilization of solid thyroid drug formulations
Pharmaceutical formulations and dosage forms are provided having improved stability to moisture-induced degradation when compared with conventional dosage forms, especially tablets. The invention...
|
|
|
6849275 |
Calcium phosphate composition and method of preparing same
A method for controlling the formation of a hydroxyapatite bone filler from dry calcium phosphate precursors in an aqueous solution uses coated sodium phosphate powder. The sodium phosphate powder...
|
|
|
6849269 |
Proliposomal drug delivery system
This invention relates to proliposomal drug-delivery systems for medicaments. In particular, it relates to enteric-coated proliposomal formulations for poorly water soluble drugs and methods for...
|
|
|
6780436 |
Solid oral pharmaceutical formulation of modified release that contains an acid labile benzimidazole compound
The pharmaceutical formulation consists of a number of pellets that comprise an inert nucleus, a layer with the active ingredient, one or more intermediate layers that comprise at least a system of...
|
|
|
6749867 |
Delivery system for omeprazole and its salts
The present invention provides a time-release dosage form for delivering an acid-labile pharmaceutical, such as omeprazole, into the upper portion of the gastrointestinal tract downstream of the...
|
|
|
6749864 |
Stabilized pharmaceutical composition
The pharmaceutical composition of the invention, which comprises a benzimidazole compound of the formula wherein R 1 is hydrogen, alkyl, halogen, cyano, carboxy, carboalkoxy, carboalkoxyalkyl,...
|
|
|
6737082 |
Pharmaceutical oral preparation of a compound having an antifungic activity, and preparation method
It comprises a compound having antifungal activity as active principle, an inert core and a coating including said active principle, and is characterized in that said inert core has a particle size...
|
|
|
6723348 |
Orodispersible tablets containing fexofenadine
The present invention concerns orodispersible tablets, which are able to disintegrate in the buccal cavity upon contact with saliva by formation of an easy-to-swallow suspension, in less than 60...
|
|
|
6716456 |
Method for production of microcapsules
The invention provides a process for microencapsulating a pharmaceutical substrate comprising the steps of: a) adding insoluble or sparingly soluble particles of the substrate to be...
|
|
|
6709678 |
Easy to swallow oral medicament composition
An oral composition which is adapted to be dispersed in an aqueous carrier substantially immediately prior to administration comprises a multiplicity of particles comprising an active substance,...
|
|
|
6699506 |
Pharmaceutical composition with extended release of Milnacipran
The invention concerns a pharmaceutical composition with prolonged release, for oral administration of a single daily dose of 60 to 140 mg of Milnacipran, having a multi-particulate form containing...
|
|
|
6692769 |
Sustained-release particles
The present invention discloses sustained release particles having a mean particle size of 300 μm, or less, comprising a drug-containing core substance coated with a mixed coating of a hydrophobic...
|
|
|
6685964 |
Opioid analgesics with controlled active substance release
An orally administered preparation with controlled lease of an opioid analgesic in the form of crystals having particle size of 10 μm to 3 mm, preferably of 50 μm to 1 mm, which have at least one...
|
|
|
6685962 |
Gastroretentive controlled release pharmaceutical dosage forms
Pharmaceutical gastroretentive drug delivery systems for the controlled release of an active agent in the gastrointestinal tract are disclosed, which comprise: (a) a single- or multi-layered matrix...
|
|
|
6669957 |
Galenic formulations fast disintegrating in the mouth and method for preparing same
The invention relates to pharmaceutical dosage forms with rapid disintegration in the mouth and to their process of preparation. These pharmaceutical dosage forms comprise at least one active...
|
|
|
6663897 |
Oral itraconazole formulations and methods of making the same
A method of manufacturing an itraconazole oral dosage form that is substantially free of residual methylene chloride comprises the steps of: (a) providing a working solution comprising an alcohol,...
|
|
|
6630162 |
Pharmaceutical formulation and its use
The invention relates to a pharmaceutical formulation containing tolterodine or a tolterodine-related compound, or a pharmacologically acceptable salt thereof, as active ingredient, in which the...
|
|
|
6576677 |
Medicinal compositions with relieved bitterness
The present invention provides a composition alleviated in a bitter taste or the like of a medicament. The present invention relates to a composition comprising a basic medicament having an...
|
|
|
6548170 |
Treated water-insoluble solid particles, preparation and use
The present invention relates to water-insoluble solid particles, especially pigments, which characteristically are coated with at least one layer of at least one product resulting from the...
|
|
|
6534549 |
Controlled release formulations
A method for producing a controlled release composition is provided. A solution of a film-forming composition comprising a mixture of a substantially water-insoluble film-forming polymer and...
|
|
|
6509034 |
Wettable microcapsules having hydrophobic polymer coated cores
This invention concerns wettable microcapsules ethylcellulose coated cores and to processes for their preparation; in particular, to microcapsules with ethylcellulose coats that are wettable so...
|
|
|
6500455 |
Tolperison-containing, pharmaceutical preparation for oral administration
A pharmaceutical preparation containing Tolperison or a salt thereof as an active ingredient in the form of a racemic mixture which can be a 50/50/-racemat or a racemat with the perponderant...
|
|
|
6479075 |
Pharmaceutical formulations for acid labile substances
This invention in general relates to novel pharmaceutical compositions for acid labile substances as well as for methods of making such. Specifically, the invention provides a pharmaceutical...
|
|
|
6451350 |
Controlled release tramadol preparation with a storage-stable release profile and process for their production
A process for producing an oral, controlled release preparation of tramadol or a physiologically compatible tramadol salt having a storage stable active substance release profile by coating the...
|
|
|
6451345 |
Functional coating of linezolid microcapsules for taste-masking and associated formulation for oral administration
The present invention provides taste-masked microcapsules of Linezolid or the like (any member of the orally effective oxazolidinone or macrolide antibiotics), suitable for oral administration as a...
|
|
|
6436438 |
Tramadol multiple unit formulations
A multiple unit oral pharmaceutical dosage form having a plurality of pellets in a water soluble capsule or in a tablet compressed from the pellets, wherein each pellet contains (a) a substantially...
|
|
|
6432381 |
Methods for targeting drug delivery to the upper and/or lower gastrointestinal tract
Particulate crystalline therapeutic substances are formulated with stabilizers to enhance contact between the crystalline therapeutic substances and the mucosal membranes to provide extended...
|